Safety study of a new tablet in healthy adults
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests a new tablet drug in healthy people to see how safe it is and how the body processes it. It is an early-stage study, meaning it helps find the right dose and check for side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy adult aged 18 to 55.
- You have not taken any medications (including over-the-counter drugs, herbs, or vitamins) in the past 2 weeks.
- You are willing to follow strict rules: no alcohol, caffeine, smoking, or certain foods like grapefruit during the study.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
- You have not donated blood or participated in another trial in the past 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medication called RS-C1001 in healthy Chinese volunteers to see if it's safe and how the body processes it. The drug may help lower cholesterol, but the main goal here is to check for side effects.
This early-stage study tests how a new experimental medication (HSK55879) is tolerated and processed by the body in healthy volunteers. Researchers will also check how food affects the drug's absorption to help determine safe dosing for future patient studies.
This study tests a new slow-release tablet (Hemay5259) in healthy people. It aims to check how safe the drug is, how it works in the body, and whether food changes its effects. Participants will receive the drug and be closely monitored for side effects.
This study tests an experimental medication called XTYW007 to see if it is safe and how it works in the body. You would take the pills under close supervision and have your health monitored.
This study tests a single dose of a new tablet medication (called TRTL-729) in healthy adults. It helps researchers learn how the drug is absorbed and tolerated, which is a first step in developing a treatment.
This study tests a new drug called CG-0416 in healthy volunteers to see how safe it is and how the body handles it. The drug is given as a single dose or repeated doses, and researchers will monitor your health and cholesterol levels.
Hear when a new Healthy Subjects、Lipid Metabolism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.